BNIPL Antikörper (Middle Region)
Kurzübersicht für BNIPL Antikörper (Middle Region) (ABIN928647)
Target
Alle BNIPL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Aufreinigung
- Purified
-
Immunogen
- BNIPL antibody was raised in rabbit using the middle region of BNIPL as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
BNIPL Blocking Peptide, (ABIN936528), is also available for use as a blocking control in assays to test for specificity of this BNIPL antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- BNIPL (BCL2/adenovirus E1B 19kD Interacting Protein Like (BNIPL))
-
Andere Bezeichnung
- BNIPL
-
Hintergrund
- BNIPL may be a bridge molecule between BCL2 and ARHGAP1/CDC42 in promoting cell death. Synonyms: Polyclonal BNIPL antibody, Anti-BNIPL antibody, BCL2/adenovirus E1B 19kD interacting protein like antibody, BNIP-S antibody, BNIPL-1 antibody, BNIPL-2 antibody, PP753 antibody.
Target
-